President and CFO
President and CFO at BridgeBio Pharma, Inc., filing insider transactions between 2025-08-18 and 2026-05-18.
| SEC ↗ |
| 2026-02-17 | BBIO | Sale | 13.4K | $74.71 | $1.0M | SEC ↗ |
| 2025-11-17 | BBIO | Sale | 9,978 | $66.19 | $660K | SEC ↗ |
| 2025-11-17 | BBIO | Sale | 6,956 | $66.84 | $465K | SEC ↗ |
| 2025-08-21 | BBIO | Sale | 42.2K | $49.48 | $2.1M | SEC ↗ |
| 2025-08-18 | BBIO | Sale | 15.4K | $50.14 | $771K | SEC ↗ |
| 2025-08-18 | BBIO | Sale | 1,973 | $50.94 | $101K | SEC ↗ |